1. Home
  2. FSBC vs PLRX Comparison

FSBC vs PLRX Comparison

Compare FSBC & PLRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Five Star Bancorp

FSBC

Five Star Bancorp

HOLD

Current Price

$46.19

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

Logo Pliant Therapeutics Inc.

PLRX

Pliant Therapeutics Inc.

HOLD

Current Price

$1.17

Market Cap

73.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSBC
PLRX
Founded
2002
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
73.7M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
FSBC
PLRX
Price
$46.19
$1.17
Analyst Decision
Buy
Hold
Analyst Count
5
4
Target Price
$41.90
$2.67
AVG Volume (30 Days)
133.7K
437.8K
Earning Date
04-27-2026
05-06-2026
Dividend Yield
2.47%
N/A
EPS Growth
28.32
29.97
EPS
1.78
N/A
Revenue
N/A
N/A
Revenue This Year
$30.25
N/A
Revenue Next Year
$12.30
N/A
P/E Ratio
$25.79
N/A
Revenue Growth
N/A
N/A
52 Week Low
$30.68
$1.02
52 Week High
$50.26
$1.95

Technical Indicators

Market Signals
Indicator
FSBC
PLRX
Relative Strength Index (RSI) 51.34 55.13
Support Level $44.68 $1.12
Resistance Level $47.57 $1.26
Average True Range (ATR) 0.94 0.04
MACD 0.14 0.00
Stochastic Oscillator 70.04 57.87

Price Performance

Historical Comparison
FSBC
PLRX

About FSBC Five Star Bancorp

Five Star Bancorp is a bank holding company that operates in California through its subsidiary, a state-chartered non-member bank. The company provides a broad range of banking products and services to small and medium-sized businesses, professionals, and individuals. It offers loan products like commercial real estate loans, commercial loans, commercial land and construction loans, and farmland loans, and offers deposit products like checking accounts, savings accounts, money market accounts, and term certificate accounts. The group has one reportable operating segment: Banking.

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.

Share on Social Networks: